Stifel Nicolaus Has Lowered Expectations for agilon health (NYSE:AGL) Stock Price

agilon health (NYSE:AGL) had its price target decreased by Stifel Nicolaus from $7.00 to $2.00 in a research note released on Tuesday,Benzinga reports. Stifel Nicolaus currently has a hold rating on the stock.

Several other brokerages have also recently commented on AGL. Royal Bank of Canada restated an “outperform” rating and set a $8.00 target price on shares of agilon health in a report on Wednesday, August 7th. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a report on Wednesday, October 2nd. William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. JMP Securities cut agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday. Finally, Barclays lowered their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research report on Monday. Three research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, agilon health has an average rating of “Hold” and an average target price of $7.03.

agilon health Trading Down 13.7 %

Shares of NYSE:AGL opened at $1.87 on Tuesday. The firm has a market cap of $767.41 million, a price-to-earnings ratio of -1.98 and a beta of 0.60. agilon health has a 12 month low of $1.80 and a 12 month high of $13.76. The company’s fifty day simple moving average is $3.22 and its 200 day simple moving average is $4.95. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04.

agilon health (NYSE:AGL) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 46.06% and a negative net margin of 6.88%. The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period in the prior year, the company earned ($0.06) earnings per share. As a group, research analysts forecast that agilon health will post -0.32 EPS for the current fiscal year.

Insider Activity

In other agilon health news, CEO Steven Sell acquired 20,000 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was purchased at an average price of $3.36 per share, with a total value of $67,200.00. Following the acquisition, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.20% of the stock is currently owned by company insiders.

Institutional Trading of agilon health

Large investors have recently modified their holdings of the stock. Arizona State Retirement System lifted its position in agilon health by 2.5% during the second quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock worth $562,000 after purchasing an additional 2,070 shares during the period. Swiss National Bank boosted its position in shares of agilon health by 0.6% during the 1st quarter. Swiss National Bank now owns 602,800 shares of the company’s stock worth $3,677,000 after acquiring an additional 3,400 shares in the last quarter. J.Safra Asset Management Corp increased its stake in agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after acquiring an additional 3,625 shares during the last quarter. CWM LLC raised its position in agilon health by 406.5% during the second quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after purchasing an additional 7,288 shares in the last quarter. Finally, Signaturefd LLC lifted its stake in agilon health by 166.2% during the second quarter. Signaturefd LLC now owns 11,848 shares of the company’s stock worth $77,000 after purchasing an additional 7,398 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.